Wishing you all the joys of the season! 
North America Flowable Hemostats Market Forecast to 2028
North America Flowable Hemostats Market Forecast to 2028 – Regional Analysis – by Material (Porcine Gelatin and Bovine Gelatin), Product (Active Hemostats, Passive Hemostats, and Combination Hemostats), Application (General Surgery, Cardiac Surgery, Vascular Surgery, Orthopedic Surgery, Neuro & Spine Surgery, and Others), and End User (Hospital & Clinics, Ambulatory Surgery Centers, and Others)
$2,485 – $3,885
- Description
- Toplines
- Reasons for Buying
- Table of Contents
- List of Tables
- LIst of Figures
- List of Companies
- Reviews (0)
Description
Research and Development (R&D) Activities Leading to Product Innovations Fuel North America Flowable Hemostats Market
Hemostat products are high in demand in the healthcare industry. Over the past several years, many hemostat products have been developed and utilized in several surgical procedures. Researchers are carrying out intensive research and development activities resulting in product innovations. For Instance, In December 2019, Ethicon’s (Johnson & Johnson Medical Device Companies) new product, “SURGIFLO Hemostatic Matrix.” SURGIFLOW flowable hemostatic product stops bleeding while performing surgery and is faster than FLOSEAL (manufactured by Baxter). Furthermore, In January 2018, Z-Medica, LLC, a leading developer and marketer of hemostatic devices introduced QuikClot Control+ which can help save lives and fill the unmet need of hospitals across the country. QuikClot Control+ is indicated for temporary control of internal organ space bleeding for patients displaying class III or class IV bleeding. It may even be used to control severe bleeding wounds such as surgical wounds and traumatic injuries. Thus, research and development activities leading to product innovations are predicted to deliver an impetus for the growth of the overall flowable hemostats market during the forecast period.
North America Flowable Hemostats Market Overview
Hemostat products are high in demand in the healthcare industry. Over the past several years, many hemostat products have been developed and utilized in several surgical procedures. Researchers are carrying out intensive research and development activities resulting in product innovations. For Instance, In December 2019, Ethicon’s (Johnson & Johnson Medical Device Companies) new product, “SURGIFLO Hemostatic Matrix.” SURGIFLOW flowable hemostatic product stops bleeding while performing surgery and is faster than FLOSEAL (manufactured by Baxter). Furthermore, In January 2018, Z-Medica, LLC, a leading developer and marketer of hemostatic devices introduced QuikClot Control+ which can help save lives and fill the unmet need of hospitals across the country. QuikClot Control+ is indicated for temporary control of internal organ space bleeding for patients displaying class III or class IV bleeding. It may even be used to control severe bleeding wounds such as surgical wounds and traumatic injuries. Thus, research and development activities leading to product innovations are predicted to deliver an impetus for the growth of the overall flowable hemostats market during the forecast period.
North America Flowable Hemostats Market Revenue and Forecast to 2028 (US$ Million)
North America Flowable Hemostats Market Segmentation
The North America flowable hemostats market is segmented into material, product, application, end user, and country.
Based on material, the North America flowable hemostats market is bifurcated into bovine gelatin & porcine gelatin. The bovine gelatin segment held a larger share of the North America flowable hemostats market in 2022.
In terms of product, the North America flowable hemostats market is segmented into combination hemostats, passive hemostats, and active hemostats. The combination hemostats segment held the largest share of the North America flowable hemostats market in 2022.
Based on Application, the North America flowable hemostats market is categorized into general surgery, cardiac surgery, vascular surgery, orthopedic surgery, neuro and spine surgery, and others. The general surgery segment held the largest share of the North America flowable hemostats market in 2022.
Based on end user, the North America flowable hemostats market is segmented into hospitals and clinics, ambulatory surgery centers, and others. The hospitals and clinics segment held the largest share of the North America flowable hemostats market in 2022.
By country, the North America flowable hemostats market is categorized into the US, Canada, and Mexico. The US dominated the North America flowable hemostats market in 2022.
Baxter International Inc, Ethicon (Johnson & Johnson), Pfizer Inc, Teleflex Incorporated, 3-D Matrix Medical Technology, Biom’up, and Aegis Lifesciences are some of the leading companies operating in the North America North America flowable hemostats market.
Summary Info
| Industry: | |
|---|---|
| Pricing options: | |
| Geographical coverage: | |
| Year of Publication: |
According to the Research Team’ research, the North America flowable hemostats market was valued at US$ 494.74 million in 2022 and is expected to reach US$ 742.49 million by 2028, registering a CAGR of 7.0% from 2022 to 2028. Increasing number of injuries and surgical procedures and rising geriatric population attributed to the North America flowable hemostats market expansion is among the critical factors attributed to the Asia Pacific consent management market expansion.
Injuries are still a significant concern to public health. An increase in global trauma and accident cases is a major driver of the North America Flowable hemostats market. According to World Health Organization (WHO), annually approximately 1.3 million people cut short their lives because of a road traffic crash. Between 20 to 50 million people suffer non-fatal injuries, with many incurring a disability because of their injury. Globally, hemorrhage or excessive bleeding is responsible for over one-third of pre-hospital deaths and over 40% of deaths within the first 24 hours. Furthermore, a study conducted by the U.S. Armed Forces suggested that 25% of battlefield fatalities are medically preventable. Nearly 90% of these deaths are due to uncontrolled blood loss. This resulted in a rising number of surgical procedures. The number of surgeries is rising owing to the increasing musculoskeletal disorders related with sports, occupational injuries, and age-related dysfunction. However, a substantial proportion of health gains are lost owing to sports-related injuries. Moreover, team ball sports account for almost 40% of hospital-treated sports injuries BMJ Publishing Group Ltd. report. Concussions are a major cause of mortality and morbidity and are considered the most diffuse brain injuries accountable for inducing mental status alterations. Thus, increasing number of injuries and surgical procedures are responsible for the high adoption of flowable hemostats, thereby driving the market’s growth during the forecast period.
On the contrary, shortage of skilled professionals and poor reimbursement policies hamper the North America flowable hemostats market.
Based on material, the North America flowable hemostats market is bifurcated into bovine gelatin & porcine gelatin. The bovine gelatin segment held 61.9% share of North America flowable hemostats market in 2022, amassing US$ 306.30 million. It is projected to garner US$ 465.52 million by 2028 to expand at 7.2% CAGR during 2022-2028.
In terms product, the North America flowable hemostats market is segmented into combination hemostats, passive hemostats, and active hemostats. The combination hemostats segment held 55.9% share of North America flowable hemostats market in 2022, amassing US$ 276.67 million. It is projected to garner US$ 423.29 million by 2028 to expand at 7.3% CAGR during 2022-2028.
Based on application, the North America flowable hemostats market is categorized into general surgery, cardiac surgery, vascular surgery, orthopedic surgery, neuro and spine surgery, and others. The general surgery segment held 34.6% share of North America flowable hemostats market in 2022, amassing US$ 171.32 million. It is projected to garner US$ 271.55 million by 2028 to expand at 8.0% CAGR during 2022-2028.
Based on end user, the North America flowable hemostats market is segmented into hospitals and clinics, ambulatory surgery centers, and others. The hospitals and clinics segment held 67.7% share of North America flowable hemostats market in 2022, amassing US$ 335.10 million. It is projected to garner US$ 499.63 million by 2028 to expand at 6.9% CAGR during 2022-2028.
By country, the North America flowable hemostats market has been categorized into the US, Canada, and Mexico. Our regional analysis states that the US captured 84.8% share of North America flowable hemostats market in 2022. It was assessed at US$ 419.40 million in 2022 and is likely to hit US$ 638.27 million by 2028, exhibiting a CAGR of 7.2% during 2022-2028.
Key players operating in the North America flowable hemostats market Baxter International Inc, Ethicon (Johnson & Johnson), Pfizer Inc, Teleflex Incorporated, 3-D Matrix Medical Technology, Biom’up, and Aegis Lifesciences, among others.
In April 2019, The Baxter International announced that it has received US Food and Drug Administration (FDA) approval for faster preparation of its leading hemostatic, Floseal Hemostatic Matrix, at the 2019 Association of periOperative Registered Nurses (AORN) Global Surgical Conference and Expo. This next generation of Floseal has 20 percent fewer components and steps to prepare, 1 making it easier and faster for operating room (OR) nurses to get Floseal in the hands of surgeons to help stop bleeding during procedures.
In Dec-19, Johnson and Johnson’s Ethicon unit has launched its blood-stopping protein spray, designed to quickly seal off and control excessive bleeding during open surgeries or minimally invasive procedures. According to Ethicon, it’s the first fibrin sealant designed to be used without a gas propellant. Delivered in a pre-filled syringe, the spray is designed to rapidly adhere and form a clot over the bleed, and has shown clinical success in high-risk patients-such as those with multiple factors including bleeding disorders, diabetes or organ failure, or patients taking blood thinners or antiplatelet therapies.
o Highlights key business priorities to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in North America flowable hemostats market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth North America market trends and outlook coupled with the factors driving the market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 the Research Team Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Flowable Hemostats Market – By Material
1.3.2 North America Flowable Hemostats Market – By Product
1.3.3 North America Flowable Hemostats Market – By Application
1.3.4 North America Flowable Hemostats Market – By End User
1.3.5 North America Flowable Hemostats Market – By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Flowable Hemostats Market – Market Landscape
4.1 Overview
4.2 North America PEST Analysis
4.2.1 North America PEST Analysis
4.3 North America Experts Opinion
5. North America Flowable Hemostats Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Number of Injuries and Surgical Procedures
5.1.2 Rising Geriatric Population
5.2 Market Restraints
5.2.1 Shortage of Skilled Professionals and Poor Reimbursement Policies
5.3 Market Opportunities
5.3.1 Increasing Number of Hospitals and Surgical Centers
5.4 Future Trends
5.4.1 Research and Development (R&D) Activities Leading to Product Innovations
5.5 Impact Analysis
6. Flowable Hemostats Market – North America Analysis
6.1 North America Flowable Hemostats Market Revenue Forecast & Analysis
7. North America Flowable Hemostats Market Revenue Forecast & Analysis
7.1 North America Flowable Hemostats Market Analysis – By Material
7.2 North America Flowable Hemostats Market Share, by Material, 2021 and 2028 (%)
7.3 Bovine Gelatin
7.3.1 Overview
7.3.2 Bovine Gelatin: North America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
7.4 Porcine Gelatin
7.4.1 Overview
7.4.2 Porcine Gelatin: North America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
8. North America Flowable Hemostats Market- By Product
8.1 Overview
8.2 North America Flowable Hemostats Market Share, by Product, 2021 and 2028 (%)
8.3 Combination Hemostat
8.3.1 Overview
8.3.2 Combination Hemostat: North America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
8.4 Passive Hemostat
8.4.1 Overview
8.4.2 Passive Hemostat: North America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
8.5 Active Hemostat
8.5.1 Overview
8.5.2 Active Hemostat: North America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
9. North America Flowable Hemostats Market- By Application
9.1 Overview
9.2 North America Flowable Hemostats Market Share, by Application, 2021 and 2028 (%)
9.3 General Surgery
9.3.1 Overview
9.3.2 General Surgery: North America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
9.4 Cardiac Surgery
9.4.1 Overview
9.4.2 Cardiac Surgery: North America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
9.5 Vascular Surgery
9.5.1 Overview
9.5.2 Vascular Surgery: North America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
9.6 Orthopedic Surgery
9.6.1 Overview
9.6.2 Orthopedic Surgery: North America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
9.7 Neuro and Spine Surgery
9.7.1 Overview
9.7.2 Neuro and Spine Surgery: North America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
9.8 Others
9.8.1 Overview
9.8.2 Others: North America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
10. North America Flowable Hemostats Market Analysis – By End User
10.1 Overview
10.2 North America Flowable Hemostats Market Share, by End User, 2021 and 2028, (%)
10.3 Hospitals and Clinics
10.3.1 Overview
10.3.2 Hospitals and Clinics: North America Flowable Hemostats Market – Revenue and Forecast to 2028 (US$ Million)
10.4 Ambulatory Surgery Centers
10.4.1 Overview
10.4.2 Ambulatory Surgery Centers: North America Flowable Hemostats Market – Revenue and Forecast to 2028 (US$ Million)
10.5 Others
10.5.1 Overview
10.5.2 Others: North America Flowable Hemostats Market – Revenue and Forecast to 2028 (US$ Million)
11. North America Flowable Hemostats Market Revenue and Forecasts to 2028 – Country Analysis
11.1 North America: Flowable Hemostats Market
11.1.1 Overview
11.1.2 North America: Flowable Hemostats Market, by Country, 2022 & 2028 (%)
11.1.2.1 US: Flowable Hemostats Market – Revenue and Forecast to 2028 (US$ Million)
11.1.2.1.1 Overview
11.1.2.2 US: Flowable Hemostats Market – Revenue and Forecast to 2028 (USD Million)
11.1.2.2.1 US: Flowable Hemostats Market, by Material- Revenue and Forecast to 2028 (USD Million)
11.1.2.2.2 US: Flowable Hemostats Market, by Product- Revenue and Forecast to 2028 (USD Million)
11.1.2.2.3 US: Flowable Hemostats Market, by Application- Revenue and Forecast to 2028 (USD Million)
11.1.2.2.4 US: Flowable Hemostats Market, End User – Revenue and Forecast to 2028 (USD Million)
11.1.2.3 Canada: Flowable Hemostats Market – Revenue and Forecast to 2028 (US$ Million)
11.1.2.3.1 Overview
11.1.2.3.2 Canada: Flowable Hemostats Market – Revenue and Forecast to 2028 (USD Million)
11.1.2.3.3 Canada: Flowable Hemostats Market, by Material- Revenue and Forecast to 2028 (USD Million)
11.1.2.3.4 Canada: Flowable Hemostats Market, by Product- Revenue and Forecast to 2028 (USD Million)
11.1.2.3.5 Canada: Flowable Hemostats Market, by Application- Revenue and Forecast to 2028 (USD Million)
11.1.2.3.6 Canada: Flowable Hemostats Market, End User – Revenue and Forecast to 2028 (USD Million)
11.1.2.4 Mexico: Flowable Hemostats Market – Revenue and Forecast to 2028 (US$ Million)
11.1.2.4.1 Overview
11.1.2.4.2 Mexico: Flowable Hemostats Market – Revenue and Forecast to 2028 (USD Million)
11.1.2.4.3 Mexico: Flowable Hemostats Market, by Material- Revenue and Forecast to 2028 (USD Million)
11.1.2.4.4 Mexico: Flowable Hemostats Market, by Product- Revenue and Forecast to 2028 (USD Million)
11.1.2.4.5 Mexico: Flowable Hemostats Market, by Application- Revenue and Forecast to 2028 (USD Million)
11.1.2.4.6 Mexico: Flowable Hemostats Market, End User – Revenue and Forecast to 2028 (USD Million)
12. North America Flowable Hemostats Market-Industry Landscape
12.1 Overview
12.2 Growth Strategies in the Flowable Hemostats Market (%)
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic Developments
12.4.1 Overview
13. Company Profiles
13.1 Baxter International Inc
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Ethicon (Johnson & Johnson)
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Pfizer Inc.
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Teleflex Incorporated
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 3-D Matrix Medical Technology
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Biom’up
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Aegis Lifesciences
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
14. Appendix
14.1 About the Research Team
14.2 North America Glossary of Terms
LIST OF TABLES
Table 1. US: Flowable Hemostats Market, by Material – Revenue and Forecast to 2028 (USD Million)
Table 2. US: Flowable Hemostats Market, by Product- Revenue and Forecast to 2028 (USD Million)
Table 3. US: Flowable Hemostats Market, by Application- Revenue and Forecast to 2028 (USD Million)
Table 4. US: Flowable Hemostats Market, End User – Revenue and Forecast to 2028 (USD Million)
Table 5. Canada: Flowable Hemostats Market, by Material – Revenue and Forecast to 2028 (USD Million)
Table 6. Canada: Flowable Hemostats Market, by Product- Revenue and Forecast to 2028 (USD Million)
Table 7. Canada: Flowable Hemostats Market, by Application- Revenue and Forecast to 2028 (USD Million)
Table 8. Canada: Flowable Hemostats Market, End User – Revenue and Forecast to 2028 (USD Million)
Table 9. Mexico: Flowable Hemostats Market, by Material – Revenue and Forecast to 2028 (USD Million)
Table 10. Mexico: Flowable Hemostats Market, by Product- Revenue and Forecast to 2028 (USD Million)
Table 11. Mexico: Flowable Hemostats Market, by Application- Revenue and Forecast to 2028 (USD Million)
Table 12. Mexico: Flowable Hemostats Market, End User – Revenue and Forecast to 2028 (USD Million)
Table 13. Organic Developments in the Flowable Hemostats Market
Table 14. Inorganic Developments in the Flowable Hemostats Market
Table 15. North America Glossary of Terms
LIST OF FIGURES
Figure 1. North America Flowable Hemostats Market Segmentation
Figure 2. North America Flowable Hemostats Market, By Country
Figure 3. North America Flowable Hemostats Market Overview
Figure 4. Bovine Gelatin Holds Maximum Share in North America Flowable Hemostats Market
Figure 5. North America Flowable Hemostats Market, by Country (US$ Million)
Figure 6. North America Flowable Hemostats Market, Market Attractiveness
Figure 7. North America: PEST Analysis
Figure 8. North America Experts Opinion
Figure 9. Impact Analysis
Figure 10. North America Flowable Hemostats Market – Revenue Forecast and Analysis – 2020- 2028
Figure 11. North America Flowable Hemostats market Share, by Material, 2021 and 2028 (%)
Figure 12. Bovine Gelatin: North America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
Figure 13. Porcine Gelatin: North America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
Figure 14. North America Flowable Hemostats Market Share, by Product, 2021 and 2028 (%)
Figure 15. Combination Hemostat: North America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
Figure 16. Passive Hemostat: North America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
Figure 17. Active Hemostat: North America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
Figure 18. North America Flowable Hemostats Market Share, by Application, 2021 and 2028 (%)
Figure 19. General Surgery: North America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
Figure 20. Cardiac Surgery: North America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
Figure 21. Vascular Surgery: North America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
Figure 22. Orthopedic Surgery: North America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
Figure 23. Neuro and Spine Surgery: North America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
Figure 24. Others: North America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
Figure 25. North America Flowable Hemostats Gown Market Share, by End User, 2021 and 2028 (%)
Figure 26. Hospitals and Clinics: North America Flowable Hemostats Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. Ambulatory Surgery Centers: North America Flowable Hemostats Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. Others: North America Flowable Hemostats Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. North America Flowable Hemostats Market Revenue Overview, by Country, 2021 (US$ MN)
Figure 30. North America: Flowable Hemostats Market, by Country, 2022 & 2028 (%)
Figure 31. US: Flowable Hemostats Market Revenue and Forecast to 2028 (US$ Mn)
Figure 32. Canada: Flowable Hemostats Market Revenue and Forecast to 2028 (US$ Mn)
Figure 33. Mexico: Flowable Hemostats Market Revenue and Forecast to 2028 (US$ Mn)
Figure 34. Growth Strategies in the Flowable Hemostats Market (%)
The List of Companies – North America Flowable Hemostats Market
1. Baxter International Inc
2. Ethicon (Johnson & Johnson)
3. Pfizer Inc
4. Teleflex Incorporated
5. 3-D Matrix Medical Technology
6. Biom’up
7. Aegis Lifesciences
You must be logged in to post a review.
Reviews
There are no reviews yet.